Related references
Note: Only part of the references are listed.Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance
Masoud Najafi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
Wen-juan Liu et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
Teodora Costea et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Wnt/β-catenin-mediated heat exposure inhibits intestinal epithelial cell proliferation and stem cell expansion through endoplasmic reticulum stress
Jia-yi Zhou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
Raefa Abou Khouzam et al.
SEMINARS IN CANCER BIOLOGY (2020)
Transmissible gastroenteritis virus targets Paneth cells to inhibit the self-renewal and differentiation of Lgr5 intestinal stem cells via Notch signaling
Aimin Wu et al.
CELL DEATH & DISEASE (2020)
Metabolic gene NR4A1 as a potential therapeutic target for non-smoking female non-small cell lung cancer patients
Rong Sun et al.
THORACIC CANCER (2019)
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Najah Albadari et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Racheal G. Akwii et al.
CELLS (2019)
High baseline Tie1 level predicts poor survival in metastatic breast cancer
Leena Tiainen et al.
BMC CANCER (2019)
Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness
Michela Terlizzi et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Global Epidemiology of Lung Cancer
Julie A. Barta et al.
ANNALS OF GLOBAL HEALTH (2019)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and sternness
Jingjing Wang et al.
CANCER LETTERS (2018)
Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis
Silvia La Porta et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
Tianxiao Gong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1
Yuhong Lu et al.
MOLECULAR CANCER RESEARCH (2018)
Notch Signaling Enhances Stemness by Regulating Metabolic Pathways Through Modifying p53, NF-κB, and HIF-1α
Hiroyuki Moriyama et al.
STEM CELLS AND DEVELOPMENT (2018)
Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer
Masumi Ishibashi et al.
SCIENTIFIC REPORTS (2018)
Elevated expression of Tie1 is accompanied by acquisition of cancer stemness properties in colorectal cancer
Miku Torigata et al.
CANCER MEDICINE (2017)
Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α
Jennifer Petra Schoning et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
HIF-1 at the crossroads of hypoxia, inflammation, and cancer
Kuppusamy Balamurugan
INTERNATIONAL JOURNAL OF CANCER (2016)
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics
Ting-Yuan David Cheng et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways
Gemma Leon et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Hypoxic control of metastasis
Erinn B. Rankin et al.
SCIENCE (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
Jiezhong Chen et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
Yingqian Lv et al.
ONCOTARGETS AND THERAPY (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α
Xiaochen Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K/Akt signal
Rui Du et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells
Ying Tong et al.
FEBS LETTERS (2013)
Hypoxia-inducible factor-1 alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition
Shiren Sun et al.
KIDNEY INTERNATIONAL (2009)
Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1
BD Kelly et al.
CIRCULATION RESEARCH (2003)
Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes
K Miyazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
